Streptolev 15,00,000IU Injection

Streptolev 15,00,000IU injection contains streptokinase as its active component. It is a medication used in the treatment of thromboembolic conditions.

The injection is indicated for deep vein thrombosis, a condition characterised by blood clot formation in the deep veins, commonly in the legs. It is used to treat pulmonary embolism, which occurs when a blood clot lodges in the lungs and obstructs blood flow. In certain cases, it is used for arterial thrombosis, such as clots that may cause ischaemic strokes. Streptolev 15,00,000IU injection is used to maintain patency of dialysis fistulas or grafts—artificial connections between an artery and a vein used in patients with renal failure requiring dialysis.

Streptolev 15,00,000IU injection is contraindicated in patients with known hypersensitivity or allergic reaction to streptokinase or any components of the formulation. It should not be administered in the presence of active internal bleeding, such as gastrointestinal bleeding or recent surgery. Patients with a history of haemorrhagic stroke should not receive this medication. It is contraindicated in patients with severe renal dysfunction. Older patients require evaluation by a healthcare provider due to increased bleeding risk associated with age-related changes in blood vessels and concurrent medical conditions. Streptolev 15,00,000IU injection is generally not recommended in paediatric populations due to limited safety and efficacy data in this age group.

Streptolev 15,00,000IU injection is used in the following: Myocardial Infarction (heart attack) Deep vein thrombosis (DVT) Pulmonary embolism Arterial clots Peripheral arterial disease Thrombosis in dialysis fistulas/grafts

Streptolev 15,00,000IU injection operates as a thrombolytic agent by interacting with plasminogen, a precursor protein in the blood. Through its binding, It triggers plasminogen's conversion into plasmin, an active enzyme that dismantles fibrin, the structural framework of blood clots, leading to their dissolution. Promoting this clot breakdown restores blood flow by eliminating blockages in blood vessels, which is essential for preventing tissue damage and related complications.

Streptolev 15,00,000IU injection is administered through the intravenous (IV) route or intracoronory. It may also be delivered through an arterial catheter for more localized treatment. Healthcare professionals perform administration following prescribed dosages and guidelines.

Streptolev 15,00,000IU injection causes some side effects like all medications, although not everyone will experience them. Serious Bleeding Allergic Reactions Hypotension (Low Blood Pressure) Fever and Chills Common Bleeding at Injection Site Nausea and Vomiting Fever Allergic Skin Reactions Minor Drop in Blood Pressure Flushing

Monitor for signs of allergic reactions, including rash, itching, swelling, and difficulty breathing. Discontinue Streptolev 15,00,000IU injection and seek medical attention immediately if any allergic symptoms occur. Use with caution in individuals with a history of bleeding disorders, recent surgery, ulcers, or other conditions that might increase bleeding risk. Monitor blood pressure during administration and address any hypotensive episodes. Follow the prescribed dosage as directed by your healthcare provider. Individuals with severe liver or kidney impairment should talk to healthcare providers to assess their condition and determine the appropriate course of action. Use this medication with caution in individuals who have recently undergone surgery, or had significant trauma.